ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

Contributed by: PR Newswire

Tags

ThinkCyte-Biopharma

More Like This

ThinkCyte Secures $32 million in Series C Funding to Drive Global Expansion of VisionSort™

PR Newswire associated0

Hamamatsu Photonics introduces CYTOQUBE, a new cell analyzer combining light-sheet optics and image analysis in a fast, user-friendly system for 3D cell screening assays

PR Newswire associated0

Cellply launches its end-to-end single cell potency characterization platform VivaCyte

CytoTronics is launching its high-throughput Pixel™ Octo system (right) at the International Society for Stem Cell Research (ISSCR 2024) in Hamburg, Germany. The ISSCR conference also marks the European reveal of CytoTronics’ product portfolio, including the entry-level Pixel Primo (left), a single plate reader that brings accessibility to researchers. (Photo: Business Wire)

CytoTronics Breaks Scalability Barriers for Monitoring Live Cell Function, Reveals Pixel Octo for High-Throughput Cell Biology Discovery Applications

Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

Biognosys Presents Technological Innovations and Scientific Progress to Make the Proteome Actionable for Life Science Research at the HUPO 2023 World Congress

PR Newswire associated0

Menarini Silicon Biosystems announces publication of the DETECT III trial results highlighting the potential clinical utility of HER2 testing in circulating tumor cells with CELLSEARCH

CRISPR-Ready ioGlutamatergic Neurons (Graphic: Business Wire)

bit.bio introduces first product in groundbreaking ioCRISPR-Ready Cells™ product range, paving the way for new advances in disease modelling and drug discovery